patients after total knee replacement M17
Conditions
Interventions
Group 1: Module 1 (early/moderate OA): Patients with knee pain (VAS = 3) will be interviewed at T0 (start of rehabilitation), T1 (end of rehabilitation) and T2 (6 months follow-up) with the questionna
Sponsors
Ludwig Boltzmann Institut für Arthritis und Rehabilitation
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Module 1: Knee pain greater than or equal to 3 (VAS) Module 2: Follow-up treatment KTEP Module 3: end-stage OA, patient directly before KTEP Men not older than 65, women not older than 60
Exclusion criteria
Exclusion criteria: Cortisone treatment (excl. inhalation), rheumatoid arthritis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 3 weeks after inpatient rehabilitation (T1): KOOS (knee pain and function), EQ-5D (quality of life), WAI (work ability index), VAS (pain) Blood parameters/cartilage remodeling: blood sampling and ELISA | — |
Secondary
| Measure | Time frame |
|---|---|
| Follow-up 6 months after inpatient rehabilitation (T2): KOOS (knee pain and function), EQ-5D (quality of life), WAI (work ability index), pain scale 0-10 (pain). | — |
Countries
Austria
Outcome results
None listed